Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study-Reference-Cited by-同舟云学术

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study

Published:2014-09-26 Issue:12 Volume:89 Page:1111-1115
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Wassie Emnet A.¹,Itzykson Raphael²,Lasho Terra L.¹,Kosmider Olivier³,Finke Christy M.¹,Hanson Curtis A.⁴,Ketterling Rhett P.⁵,Solary Eric⁶⁷⁸,Tefferi Ayalew¹,Patnaik Mrinal M.¹

Affiliation:

1. Division of Hematology; Mayo Clinic; Rochester MN

2. Université Paris Descartes; Paris France

3. Institute Cochin; Paris France

4. Division of Hematopathology; Mayo Clinic; Rochester MN

5. Division of Cytogenetics; Mayo Clinic; Rochester MN

6. Institut Gustave Roussy; Villejuif France

7. INSERM U1009; Villejuif France

8. Université Paris-Sud 11; Orsay France

Publisher

Wiley

Subject

Hematology

Reference29 articles.

1. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients;Onida;Blood,2002

2. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance;Patnaik;Am J Hematol,2013

3. Cytogenetic risk stratification in chronic myelomonocytic leukemia;Such;Haematologica,2011

4. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution;Tang;Am J Hematol,2014

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia;Leukemia & Lymphoma;2024-07-14

3. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

4. Chronic Myelomonocytic Leukemia;Cancer Consult;2023-11-18

5. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10